Previous studies have shown that IGFBP3 plays a crucial role in the tumor progression in various cancers, such as colorectal cancer (26), squamous esophageal cancer (27), nasopharyngeal carcinoma (28), glioma (29), and lung adenocarcinoma (30). Here, IGFBP3 is linked to lung adenocarcinoma.